Key result
Undulation pump total artificial heart achieves up to ~20 days survival without anticoagulants or thrombus.
Why the study?
The development and evaluation of an implantable total artificial heart with an undulation pump design required assessment of survival and device performance in animal models.
May support anticoagulation-free TAH development; leaves open translation beyond short-term animal survival.
An undulation pump is a special rotary blood pump in which rotation of a brushless DC motor is transformed to an undulating motion by a disc in the pump housing attached by means of a special link mechanism. In the blood pump, a closed line between the disc and housing moves from the inlet to the outlet by this undulating disc motion, which sucks and pushes the blood from the inlet to the outlet. Because the same phenomena occurs at both sides of the disc, a continuous flow is obtained when the motor rotational speed is constant. The pump flow pattern can be easily changed from continuous flow to pulsatile flow by controlling the motor drive current pattern. A seal membrane made of segmented polyurethane protects the blood from invading the link mechanism as well as the motor. UPTAH is fabricated with two undulation pumps and two brushless DC motors. Its size is 75 mm in diameter and 80 mm long, and it has one of the great advantage of no compliance chamber required in the system. UPTAHs were implanted under cardiopulmonary bypass (CPB) into the chest cavities of 16 goats, each weighing between 41 and 72 kg. No anticoagulant and antiplatelet agent was used after the surgery. The left atrial pressure was automatically controlled to prevent its elevation and sucking of the atrial wall into the atrial cuff. The following results were obtained: (1) UPTAHs fit well into all the goats; (2) the longest survival was 19.8 days, the cause of death was bleeding from the aortic anastomosis; (3) No thrombus was observed in the blood pump despite no anticoagulant use. Hemolysis depended upon the length of CPB during surgery. When CPB time was within 2 hours, hemolysis level returned to baseline within a few days of the surgery. UPTAH is a promising implantable TAH, because of its small size and easy controllability.
No takes yet. Share an insight, caveat, or question.
Mochizuki et al. (2000) studied this question. Undulation pump total artificial heart (UPTAH) was evaluated on Survival and device performance (thrombus, hemolysis). Implantation of the undulation pump total artificial heart in 16 goats resulted in a maximum survival of 19.8 days with no thrombus observed despite the absence of anticoagulants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: